Suppr超能文献

通过嵌合半抗原设计和组合疫苗接种增强抗可卡因催化抗体的功效。

Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.

作者信息

Wenthur Cody J, Cai Xiaoqing, Ellis Beverly A, Janda Kim D

机构信息

Departments of Chemistry and Immunology, The Scripps Research Institute, La Jolla, CA 92037, United States.

Departments of Chemistry and Immunology, The Scripps Research Institute, La Jolla, CA 92037, United States.

出版信息

Bioorg Med Chem Lett. 2017 Aug 15;27(16):3666-3668. doi: 10.1016/j.bmcl.2017.07.014. Epub 2017 Jul 5.

Abstract

Given the need for further improvements in anti-cocaine vaccination strategies, a chimeric hapten (GNET) was developed that combines chemically-stable structural features from steady-state haptens with the hydrolytic functionality present in transition-state mimetic haptens. Additionally, as a further investigation into the generation of an improved bifunctional antibody pool, sequential vaccination with steady-state and transition-state mimetic haptens was undertaken. While GNET induced the formation of catalytically-active antibodies, it did not improve overall behavioral efficacy. In contrast, the resulting pool of antibodies from GNE/GNT co-administration demonstrated intermediate efficacy as compared to antibodies developed from either hapten alone. Overall, improved antibody catalytic efficiency appears necessary to achieve the synergistic benefits of combining cocaine hydrolysis with peripheral sequestration.

摘要

鉴于抗可卡因疫苗接种策略需要进一步改进,开发了一种嵌合半抗原(GNET),它将稳态半抗原的化学稳定结构特征与过渡态模拟半抗原中存在的水解功能相结合。此外,作为对产生改良双功能抗体库的进一步研究,采用了稳态和过渡态模拟半抗原的序贯接种。虽然GNET诱导了催化活性抗体的形成,但并未提高整体行为疗效。相比之下,与单独使用任一一种半抗原产生的抗体相比,GNE/GNT联合给药产生的抗体库表现出中等疗效。总体而言,提高抗体催化效率似乎是实现可卡因水解与外周隔离相结合的协同效益所必需的。

相似文献

1
Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
Bioorg Med Chem Lett. 2017 Aug 15;27(16):3666-3668. doi: 10.1016/j.bmcl.2017.07.014. Epub 2017 Jul 5.
2
Probing active cocaine vaccination performance through catalytic and noncatalytic hapten design.
J Med Chem. 2013 May 9;56(9):3701-9. doi: 10.1021/jm400228w. Epub 2013 Apr 29.
3
Probing the effects of hapten stability on cocaine vaccine immunogenicity.
Mol Pharm. 2013 Nov 4;10(11):4176-84. doi: 10.1021/mp400214w. Epub 2013 Oct 4.
4
Cocaine catalytic antibodies: the primary importance of linker effects.
Bioorg Med Chem Lett. 2001 Jan 22;11(2):87-90. doi: 10.1016/s0960-894x(00)00659-4.
5
Hapten optimization for cocaine vaccine with improved cocaine recognition.
Chem Biol Drug Des. 2014 Sep;84(3):354-63. doi: 10.1111/cbdd.12326. Epub 2014 Jul 29.
6
Hapten design for the generation of catalytic antibodies.
Appl Biochem Biotechnol. 1994 May-Jun;47(2-3):345-72. doi: 10.1007/BF02787945.
7
Flagellin as carrier and adjuvant in cocaine vaccine development.
Mol Pharm. 2015 Feb 2;12(2):653-62. doi: 10.1021/mp500520r. Epub 2015 Jan 7.
8
An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
Bioorg Med Chem. 2000 Feb;8(2):413-26. doi: 10.1016/s0968-0896(99)00302-8.
9
Catalytic antibodies: hapten design strategies and screening methods.
Bioorg Med Chem. 2004 Oct 15;12(20):5247-68. doi: 10.1016/j.bmc.2004.03.077.
10
Immune recognition, antigen design, and catalytic antibody production.
Appl Biochem Biotechnol. 1994 May-Jun;47(2-3):257-73; discussion 273-5. doi: 10.1007/BF02787939.

引用本文的文献

1
A plant-derived cocaine hydrolase prevents cocaine overdose lethality and attenuates cocaine-induced drug seeking behavior.
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Aug 30;102:109961. doi: 10.1016/j.pnpbp.2020.109961. Epub 2020 May 6.

本文引用的文献

1
Cocaine Vaccine Development: Evaluation of Carrier and Adjuvant Combinations That Activate Multiple Toll-Like Receptors.
Mol Pharm. 2016 Nov 7;13(11):3884-3890. doi: 10.1021/acs.molpharmaceut.6b00682. Epub 2016 Oct 18.
2
Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques.
Pharmacol Biochem Behav. 2016 Nov-Dec;150-151:76-86. doi: 10.1016/j.pbb.2016.09.008. Epub 2016 Sep 30.
4
Suppression of Cocaine-Evoked Hyperactivity by Self-Adjuvanting and Multivalent Peptide Nanofiber Vaccines.
ACS Chem Neurosci. 2016 May 18;7(5):546-52. doi: 10.1021/acschemneuro.5b00345. Epub 2016 Mar 8.
5
Biologic Approaches to Treat Substance-Use Disorders.
Trends Pharmacol Sci. 2015 Oct;36(10):628-635. doi: 10.1016/j.tips.2015.07.002.
6
Is immunotherapy an opportunity for effective treatment of drug addiction?
Vaccine. 2015 Nov 27;33(48):6545-51. doi: 10.1016/j.vaccine.2015.09.079. Epub 2015 Oct 2.
8
Flagellin as carrier and adjuvant in cocaine vaccine development.
Mol Pharm. 2015 Feb 2;12(2):653-62. doi: 10.1021/mp500520r. Epub 2015 Jan 7.
10
Vaccines against drugs of abuse: where are we now?
Ther Adv Vaccines. 2014 Jul;2(4):106-17. doi: 10.1177/2051013614537818.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验